IL67647A0 - 6-aminoalkylpenicillanic acid 1,1-dioxides and derivatives thereof and pharmaceutical compositions containing them - Google Patents

6-aminoalkylpenicillanic acid 1,1-dioxides and derivatives thereof and pharmaceutical compositions containing them

Info

Publication number
IL67647A0
IL67647A0 IL67647A IL6764783A IL67647A0 IL 67647 A0 IL67647 A0 IL 67647A0 IL 67647 A IL67647 A IL 67647A IL 6764783 A IL6764783 A IL 6764783A IL 67647 A0 IL67647 A0 IL 67647A0
Authority
IL
Israel
Prior art keywords
aminoalkylpenicillanic
dioxides
derivatives
acid
pharmaceutical compositions
Prior art date
Application number
IL67647A
Other versions
IL67647A (en
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/388,323 external-priority patent/US4427678A/en
Priority claimed from US06/434,371 external-priority patent/US4452796A/en
Application filed by Pfizer filed Critical Pfizer
Publication of IL67647A0 publication Critical patent/IL67647A0/en
Publication of IL67647A publication Critical patent/IL67647A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
IL67647A 1982-01-11 1983-01-10 6-aminoalkylpenicillanic acid 1,1-dioxides and derivatives thereof and pharmaceutical compositions containing them IL67647A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US33879782A 1982-01-11 1982-01-11
US38832482A 1982-06-14 1982-06-14
US06/388,323 US4427678A (en) 1982-01-11 1982-06-14 6-Aminomethylpenicillanic acid 1,1-dioxide derivatives as beta-lactamase inhibitors
US06/434,371 US4452796A (en) 1982-06-14 1982-10-21 6-Aminoalkylpenicillanic acid 1,1-dioxides as beta-lactamase inhibitors

Publications (2)

Publication Number Publication Date
IL67647A0 true IL67647A0 (en) 1983-05-15
IL67647A IL67647A (en) 1986-08-31

Family

ID=27502592

Family Applications (1)

Application Number Title Priority Date Filing Date
IL67647A IL67647A (en) 1982-01-11 1983-01-10 6-aminoalkylpenicillanic acid 1,1-dioxides and derivatives thereof and pharmaceutical compositions containing them

Country Status (20)

Country Link
EP (1) EP0084925B1 (en)
JP (1) JPH0689005B2 (en)
AU (1) AU538468B2 (en)
BG (1) BG42676A3 (en)
CA (1) CA1190921A (en)
DD (2) DD209462A5 (en)
DE (1) DE3362826D1 (en)
DK (1) DK166883B1 (en)
ES (2) ES518912A0 (en)
FI (1) FI79112C (en)
GR (1) GR77152B (en)
HU (1) HU189211B (en)
IE (1) IE54390B1 (en)
IL (1) IL67647A (en)
NO (6) NO830046L (en)
NZ (1) NZ202982A (en)
PL (1) PL142315B1 (en)
PT (1) PT76077B (en)
RO (2) RO84910B (en)
YU (1) YU43646B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4499017A (en) * 1983-06-06 1985-02-12 Pfizer Inc. Beta-lactamase inhibiting 6-(alkoxyamino-methyl) penicillanic acid 1,1-dioxide and derivatives
US4502990A (en) * 1983-06-06 1985-03-05 Pfizer Inc. Process for 6-(aminomethyl)penicillanic acid 1,1-dioxide and derivatives thereof
JPS60239489A (en) * 1984-05-15 1985-11-28 Meiji Seika Kaisha Ltd 6-epipenicillin sulfone compound and preparation thereof
GB2206579B (en) * 1987-07-10 1991-05-29 Erba Farmitalia 6a and 6b-(substituted methyl)-penicillanic acid derivatives
US8415339B2 (en) * 2007-05-21 2013-04-09 Hans Rudolf Pfaendler Bactericidal anti-MRSA active pharmaceutical composition containing carbapenems

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4237051A (en) * 1979-04-19 1980-12-02 Schering Corporation Stereospecific production of 6- or 7-carbon-substituted-β-lactams
DE2927004A1 (en) * 1979-07-04 1981-05-27 Bayer Ag, 5090 Leverkusen PENICILLANIC ACID 1,1-DIOXIDES, THEIR PRODUCTION AND THEIR USE AS MEDICINAL PRODUCTS AS MEDICINAL PRODUCTS
US4287181A (en) * 1979-10-22 1981-09-01 Pfizer Inc. Derivatives of 6β-hydroxyalkylpenicillanic acids as β-lactamase inhibitors

Also Published As

Publication number Publication date
RO84910A (en) 1984-08-17
ES8403489A1 (en) 1984-03-16
PL142315B1 (en) 1987-10-31
FI830081A0 (en) 1983-01-10
NO841069L (en) 1983-07-12
ES518912A0 (en) 1984-03-16
HU189211B (en) 1986-06-30
NZ202982A (en) 1986-04-11
NO841068L (en) 1983-07-12
JPH0689005B2 (en) 1994-11-09
IE54390B1 (en) 1989-09-13
DD209462A5 (en) 1984-05-09
RO84910B (en) 1984-09-30
FI830081L (en) 1983-07-12
YU43646B (en) 1989-10-31
EP0084925A1 (en) 1983-08-03
IE830042L (en) 1983-07-11
ES525238A0 (en) 1985-08-16
ES8507147A1 (en) 1985-08-16
JPS58126889A (en) 1983-07-28
CA1190921A (en) 1985-07-23
FI79112C (en) 1989-11-10
DK7483A (en) 1983-07-12
AU538468B2 (en) 1984-08-16
RO87705A (en) 1985-10-31
PT76077A (en) 1983-02-01
DD218365A5 (en) 1985-02-06
NO830046L (en) 1983-07-12
DE3362826D1 (en) 1986-05-15
DK7483D0 (en) 1983-01-10
FI79112B (en) 1989-07-31
AU1023283A (en) 1983-07-21
PL240108A1 (en) 1985-08-13
EP0084925B1 (en) 1986-04-09
DK166883B1 (en) 1993-07-26
NO841070L (en) 1983-07-12
RO87705B (en) 1985-10-01
BG42676A3 (en) 1988-01-15
NO833416L (en) 1983-07-12
NO833415L (en) 1983-07-12
IL67647A (en) 1986-08-31
PT76077B (en) 1986-01-09
YU4483A (en) 1986-02-28
GR77152B (en) 1984-09-07

Similar Documents

Publication Publication Date Title
IL69347A0 (en) Methylene-diphosphonic acid derivatives,their preparation and pharmaceutical compositions containing them
IL69601A0 (en) Naphthyridine-,quinoline-and benzoxazine-carboxylic acid derivatives,their preparation and pharmaceutical compositions containing them
PH19003A (en) New 2-cyl-cycloalka (c) pyrrol-3-carboxylic acid derivatives,pharmaceutical compositions containing them and their use
PH18918A (en) 2-acyl-azabicycloalkane-3-carboxylic acid derivatives,pharmaceutical compositions containing these compounds and their use
SG6885G (en) 2-hydroxy-5-phenylazobenzoic acid derivatives and pharmaceutical compositions containing them
IL76405A (en) 1,3-diacyl-2-oxindole derivatives and pharmaceutical compositions containing them
IL65076A (en) 3,4-dihydro-5h-2,3-benzo-diazepine derivatives,their preparation and pharmaceutical compositions containing them
GB2159055B (en) Pharmaceutical compositions of 3,7,11,15-tetra-methylhexadec-1-en-3-ol
IL68323A0 (en) Phenoxyalkylcarboxylic acid derivatives,their manufacture and pharmaceutical compositions containing them
DE3275296D1 (en) Azabicyclo-(3,3,1)-nonylbenzamide derivatives, processes for their preparation, and pharmaceutical compositions containing them
IL72562A (en) 6,7-dimethoxy-4-piperidino-quinazoline derivatives and pharmaceutical compositions containing them
DE3265871D1 (en) 3-amino-2-hydroxy-4-phenylbutanoic acid derivatives and pharmaceutical composition containing the same
IL78090A (en) Substituted 1,3-thiazole sulfides,process for their preparation and pharmaceutical compositions containing them
IL75603A0 (en) 1,3-dioxanylheptenoic acid derivatives,their preparation and pharmaceutical compositions containing them
IL68619A (en) 11-oxo-11h-pyrido(2,1-h)quinazolinecarboxylic acid derivatives,their manufacture and pharmaceutical compositions containing them
IL70189A (en) 2-piperazinyl-quinazoline derivatives,their proeuction and pharmaceutical compositions containing them
IL67647A0 (en) 6-aminoalkylpenicillanic acid 1,1-dioxides and derivatives thereof and pharmaceutical compositions containing them
IL70229A0 (en) 2-penem derivatives,their manufacture and pharmaceutical compositions containing them
NZ205732A (en) Thiatriazine derivatives and pharmaceutical compositions
IL67715A0 (en) 3,3-dialkyl-and 3,3-alkylene-indoline derivatives,their production and pharmaceutical compositions containing them
IL65994A0 (en) 10-(1-aza-(2,2,2)-bicyclo-3-octyl)-10h-2-phenothiazine sulphonamide and derivatives thereof,their preparation and pharmaceutical compositions containing them
NZ203649A (en) 2-beta-d-ribofuranosylselenazole-4-carboxamide derivatives and pharmaceutical compositions
IL62326A0 (en) 7 beta-amido-3-cephem-4-carboxylic acid derivatives,their manufacture and pharmaceutical compositions containing them
IL68520A (en) 5-oxo-2-pyrrolidinepropanoic acid and derivatives thereof,their preparation and pharmaceutical compositions containing them
PH24338A (en) Nitroapovincaminic acid derivatives and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
RH Patent void